These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22532771)

  • 1. Inverse Association between Cardiac Troponin-I and Soluble Receptor for Advanced Glycation End Products in Patients with Non-ST-Segment Elevation Myocardial Infarction.
    McNair ED; Wells CR; Qureshi AM; Pearce C; Caspar-Bell G; Prasad K
    Int J Angiol; 2011 Mar; 20(1):49-54. PubMed ID: 22532771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of soluble receptor for advanced glycation end products in non-ST elevation myocardial infarction patients.
    McNair ED; Wells CR; Qureshi AM; Basran RS; Pearce C; Orvold J; Devilliers J; Prasad K
    Int J Angiol; 2009; 18(4):187-92. PubMed ID: 22477551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of high sensitivity C-reactive protein by soluble receptor for advanced glycation end products.
    McNair ED; Wells CR; Mabood Qureshi A; Basran R; Pearce C; Orvold J; Devilliers J; Prasad K
    Mol Cell Biochem; 2010 Aug; 341(1-2):135-8. PubMed ID: 20339904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble receptors for advanced glycation end products (sRAGE) as a predictor of restenosis following percutaneous coronary intervention.
    McNair ED; Wells CR; Mabood Qureshi A; Basran R; Pearce C; Orvold J; Devilliers J; Prasad K
    Clin Cardiol; 2010 Nov; 33(11):678-85. PubMed ID: 21089112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated soluble receptor for advanced glycation end product levels in patients with acute coronary syndrome and positive cardiac troponin I.
    Basta G; Del Turco S; Marchi F; Navarra T; Battaglia D; Mercuri A; Mazzone A; Berti S
    Coron Artery Dis; 2011 Dec; 22(8):590-4. PubMed ID: 22072229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease.
    Prasad K; Dhar I; Zhou Q; Elmoselhi H; Shoker M; Shoker A
    Mol Cell Biochem; 2016 Dec; 423(1-2):105-114. PubMed ID: 27714575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.
    Prasad K
    Int J Angiol; 2014 Mar; 23(1):11-6. PubMed ID: 24627612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
    Prasad K; Tiwari S
    Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
    Prasad K
    Mol Cell Biochem; 2019 Jan; 451(1-2):139-144. PubMed ID: 29961210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of a disintegrin and metalloproteinase 10 in peripheral blood mononuclear cells in type 2 diabetes mellitus patients with the acute coronary syndrome: a pilot study.
    Ragavi R; Adole PS; Vinod KV; Pillai AA
    Endocrine; 2022 Sep; 77(3):461-468. PubMed ID: 35877008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic fluctuations of advanced glycation end products and its C-terminal truncated receptor level in patients with acute ST-segment elevation myocardial infarction and undergoing diabetes or not: A retrospective study.
    Qiu H; Li WP; Shen XH; Guo XY; Hua B; Li HW
    Medicine (Baltimore); 2018 Jul; 97(30):e11278. PubMed ID: 30045252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO; Dereke J; Hillman M
    Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment.
    Prasad K
    Int J Angiol; 2020 Jun; 29(2):72-80. PubMed ID: 32476808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Advanced Glycation End Products and Its Receptors in the Pathogenesis of Cigarette Smoke-Induced Cardiovascular Disease.
    Prasad K; Dhar I; Caspar-Bell G
    Int J Angiol; 2015 Jun; 24(2):75-80. PubMed ID: 26060376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism.
    Caspar-Bell G; Dhar I; Prasad K
    Mol Cell Biochem; 2016 Mar; 414(1-2):171-8. PubMed ID: 26895319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
    Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Glycation End Products and its Soluble Receptors in the Pathogenesis of Thoracic Aortic Aneurysm.
    Prasad K; Sarkar A; Zafar MA; Shoker A; Moselhi HE; Tranquilli M; Ziganshin BA; Elefteriades JA
    Aorta (Stamford); 2016 Feb; 4(1):1-10. PubMed ID: 27766267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
    Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
    J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.
    Paradela-Dobarro B; Agra RM; Álvarez L; Varela-Román A; García-Acuña JM; González-Juanatey JR; Álvarez E; García-Seara FJ
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1050-1060. PubMed ID: 31371263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.